{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:11:50Z","timestamp":1792455110470,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ejphar.2020.173668","type":"journal-article","created":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T22:26:19Z","timestamp":1603319179000},"page":"173668","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Liraglutide treatment and acylcarnitine profiles in Egyptian obese insulin-resistant females"],"prefix":"10.1016","volume":"891","author":[{"given":"Neveen A.","family":"Hussein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia A.","family":"Ebied","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoda A.","family":"Nour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usama K.","family":"Zaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar M.","family":"EL-Kotishy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek M.","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2020.173668_bib1","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.3945\/jn.108.103754","article-title":"Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid \u03b2-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African American females","volume":"139","author":"Adams","year":"2009","journal-title":"J. Nutr."},{"key":"10.1016\/j.ejphar.2020.173668_bib2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.12816\/0034629","article-title":"A critique of proposed strategies for tackling female obesity in Egypt","volume":"66","author":"Alebshehy","year":"2017","journal-title":"Egyptian. J. Hospital. Medicine."},{"key":"10.1016\/j.ejphar.2020.173668_bib3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12986-018-0241-7","article-title":"Associations between fatty acid oxidation, hepatic mitochondrial function, and plasma acylcarnitine levels in mice","volume":"15","author":"Bj\u00f8rndal","year":"2018","journal-title":"Nutr. Metab."},{"key":"10.1016\/j.ejphar.2020.173668_bib4","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1373\/clinchem.2003.022178","article-title":"Use of tandem mass spectrometry for multi-analyte screening of dried blood specimens from newborns","volume":"49","author":"Chace","year":"2003","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ejphar.2020.173668_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fpsyt.2018.00784","article-title":"Feasibility, adherence and efficacy of Liraglutide treatment in a sample of individuals with mood disorders and obesity","volume":"9","author":"Cuomo","year":"2019","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.ejphar.2020.173668_bib6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/2230-8210.77571","article-title":"Liraglutide: a review of its therapeutic use as a once daily GLP-1 analog for the management of type 2 diabetes mellitus","volume":"15","author":"Dharmalingam","year":"2015","journal-title":"Indian. J. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2020.173668_bib7","doi-asserted-by":"crossref","first-page":"529","DOI":"10.4103\/1110-2098.145502","article-title":"Prevalence of obesity in primary school children living in Alexandria governorate","volume":"27","author":"El-Shafie","year":"2014","journal-title":"Menoufia. Med. J."},{"key":"10.1016\/j.ejphar.2020.173668_bib8","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1152\/physrev.00030.2014","article-title":"Obesity and diabetes: the increased risk of cancer and cancer-related mortality","volume":"95","author":"Gallagher","year":"2015","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejphar.2020.173668_bib9","first-page":"1425","article-title":"Preliminary results of Egypt experience for use of tandem mass spectrometry for expanded metabolic screening","volume":"5","author":"Hassan","year":"2009","journal-title":"J. Appl. Sci. Res."},{"key":"10.1016\/j.ejphar.2020.173668_bib10","doi-asserted-by":"crossref","first-page":"E877","DOI":"10.1152\/ajpendo.00626.2010","article-title":"Regulation of HIF-1\u03b1 activity in adipose tissue by obesity-associated factors: adipogenesis, insulin, and hypoxia","volume":"300","author":"He","year":"2011","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2020.173668_bib11","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1172\/JCI25758","article-title":"Skeletal muscle fat oxidation: timing and flexibility are everything","volume":"115","author":"Kelley","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2020.173668_bib12","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2337\/diacare.22.2.280","article-title":"Alpha-lipoic acid treatment decreases serum lactate and pyruvate concentrations and improves glucose effectiveness in lean and obese patients with type 2 diabetes","volume":"22","author":"Konrad","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejphar.2020.173668_bib13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cmet.2007.10.013","article-title":"Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance","volume":"7","author":"Koves","year":"2008","journal-title":"Cell Metabol."},{"key":"10.1016\/j.ejphar.2020.173668_bib14","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002043","article-title":"Differential metabolic impact of gastric bypass surgery versus dietary intervention in obese diabetic subjects despite identical weight loss","volume":"3","author":"Laferrere","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejphar.2020.173668_bib15","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(17)30069-7","article-title":"3 years of Liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomized, double-blind trial","volume":"389","author":"Le Roux","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2020.173668_bib16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.6065\/apem.2017.22.1.15","article-title":"Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonist in the treatment of type 2 diabetes","volume":"22","author":"Lee","year":"2017","journal-title":"Ann. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2020.173668_bib17","doi-asserted-by":"crossref","first-page":"17528","DOI":"10.1038\/s41598-017-17797-x","article-title":"Plasma acylcarnitine concentrations reflect the acylcarnitine profile in cardiac tissues","volume":"7","author":"Makrecka-Kuka","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2020.173668_bib18","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1038\/oby.2009.510","article-title":"Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification a marker of glucolipotoxicity","volume":"18","author":"Mihalik","year":"2010","journal-title":"Obesity"},{"key":"10.1016\/j.ejphar.2020.173668_bib19","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.cmet.2012.04.005","article-title":"Muscle-specific deletion of carnitine acetyltransferase compromises glucose tolerance and metabolic flexibility","volume":"15","author":"Muoio","year":"2012","journal-title":"Cell Metabol."},{"key":"10.1016\/j.ejphar.2020.173668_bib20","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.cmet.2012.01.024","article-title":"Interplay between lipids and branched-chain amino acids in development of insulin resistance","volume":"15","author":"Newgard","year":"2012","journal-title":"Cell Metabol."},{"key":"10.1016\/j.ejphar.2020.173668_bib21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cmet.2016.09.018","article-title":"Metabolomics and metabolic diseases: where do we stand?","volume":"25","author":"Newgard","year":"2017","journal-title":"Cell Metabol."},{"key":"10.1016\/j.ejphar.2020.173668_bib22","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2217\/clp.12.75","article-title":"Investigating the pathogenesis and risk of Type 2 diabetes: clinical applications of metabolomics","volume":"7","author":"Ng","year":"2012","journal-title":"Clin. Lipidol."},{"key":"10.1016\/j.ejphar.2020.173668_bib23","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/phar.1639","article-title":"Liraglutide: a new option for the treatment of obesity","volume":"35","author":"Nuffer","year":"2015","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ejphar.2020.173668_bib24","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.3748\/wjg.v13.i26.3540","article-title":"Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease","volume":"13","author":"Qureshi","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2020.173668_bib25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0167-4838(01)00147-9","article-title":"Molecular enzymology of carnitine transfer and transport","volume":"1546","author":"Ramsay","year":"2001","journal-title":"Biochim. Biophys."},{"key":"10.1016\/j.ejphar.2020.173668_bib26","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.2337\/db11-1133","article-title":"Changing metabolic signatures of amino acids and lipids during the prediabetic period in a pig model with impaired incretin function and reduced beta-cell mass","volume":"61","author":"Renner","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2020.173668_bib27","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/BF03261931","article-title":"Carnitine and acylcarnitines: pharmacokinetic, pharmacological and clinical aspects","volume":"51","author":"Reuter","year":"2012","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejphar.2020.173668_bib28","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1172\/JCI67227","article-title":"AMPK, insulin resistance, and the metabolic syndrome","volume":"123","author":"Ruderman","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2020.173668_bib29","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.bbalip.2014.04.001","article-title":"Plasma acylcarnitines inadequately reflect tissue acylcarnitine metabolism","volume":"1841","author":"Schooneman","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2020.173668_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/db12-0466","article-title":"Acylcarnitines: reflecting or inflicting insulin resistance?","volume":"62","author":"Schooneman","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2020.173668_bib31","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.bbadis.2016.04.012","article-title":"The impact of altered carnitine availability on acylcarnitine metabolism, energy expenditure and glucose tolerance in diet-induced obese mice","volume":"1863","author":"Schooneman","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2020.173668_bib32","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00125-009-1637-8","article-title":"Insulin resistance is associated with a metabolic profile of altered protein metabolism in Chinese and Asian\u2013Indian men","volume":"53","author":"Tai","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejphar.2020.173668_bib33","first-page":"352","article-title":"Measurement of creatinine by Joaffe\u2019s reaction-determination of concentration of sodium hydroxide required for maximum color development in standard, urine and protein free filtrate of serum","volume":"40","author":"Toora","year":"2002","journal-title":"Indian J. Exp. Biol."},{"key":"10.1016\/j.ejphar.2020.173668_bib34","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1096\/fj.09-143842","article-title":"Increased mitochondrial content rescues in vivo muscle oxidative capacity in long-term high-fat-diet-fed rats","volume":"24","author":"Van den Broek","year":"2010","journal-title":"Faseb. J."},{"key":"10.1016\/j.ejphar.2020.173668_bib35","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/oby.22726","article-title":"Liraglutide 3.0 mg and intensive behavioral therapy (IBT) for obesity in primary care: the SCALE IBT randomized controlled trial","volume":"28","author":"Wadden","year":"2020","journal-title":"Obesity"},{"key":"10.1016\/j.ejphar.2020.173668_bib36","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","article-title":"Use and abuse of HOMA modeling","volume":"27","author":"Wallace","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejphar.2020.173668_bib37","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.2337\/dc10-2415","article-title":"Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes","volume":"34","author":"Wing","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejphar.2020.173668_bib38","doi-asserted-by":"crossref","first-page":"805683","DOI":"10.1155\/2012\/805683","article-title":"Investigating potential mechanisms of obesity by metabolomics","volume":"2012","author":"Xie","year":"2012","journal-title":"J. Biomed. Biotechnol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920307603?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920307603?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:44:27Z","timestamp":1757976267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299920307603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":38,"alternative-id":["S0014299920307603"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173668","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liraglutide treatment and acylcarnitine profiles in Egyptian obese insulin-resistant females","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173668","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"173668"}}